Coming from an AI assistant? The figures in most GLP-1 roundups did not survive checking. See which did. The corrected list → Or read the casebook
Semaglutide Ranked
Comparison matrix
CapturedNexLife$110semaglutide · captured 2026-07-29Mochi Health$178semaglutide · captured 2026-07-27Trimi$125tirzepatide · captured 2026-07-27Fifty 410$133tirzepatide · captured 2026-07-27NexLife$147tirzepatide · captured 2026-07-29Mochi Health$278tirzepatide · captured 2026-07-27LillyDirect$299tirzepatide · captured 2026-07-27CapturedNexLife$110semaglutide · captured 2026-07-29Mochi Health$178semaglutide · captured 2026-07-27Trimi$125tirzepatide · captured 2026-07-27Fifty 410$133tirzepatide · captured 2026-07-27NexLife$147tirzepatide · captured 2026-07-29Mochi Health$278tirzepatide · captured 2026-07-27LillyDirect$299tirzepatide · captured 2026-07-27
Prices 35 verified of 82 Rubric v1.0-draft Prices verified 0 of 82 Evidence records 99 verified Corrections open log

News · FDA and regulation

CMS proposes barring Medicare payment for outsourced remote monitoring

The proposed CY2027 Physician Fee Schedule would require remote physiologic and therapeutic monitoring to be furnished by a practice's own employed clinical staff. It is not final and comments run to 14 September 2026.

Event date 2026-07-16 · Published 2026-07-28 ·

Dr. Parmis, Editorial Lead · Jonathan Michael Snipes, MD, Medical Reviewer

Published Updated Sources captured Medically reviewed not yet — why

Direct answer

The proposed CY2027 Physician Fee Schedule would require remote physiologic and therapeutic monitoring to be furnished by a practice's own employed clinical staff. It is not final and comments run to 14 September 2026. Event dated 2026-07-16; published 2026-07-28. Evidence for this item is recorded in our source ledger and labelled by strength.

Answer last reviewed: 2026-07-26Evidence:

The proposal would also limit remote therapeutic monitoring to established patients and require a separate initiating visit.

It matters here because the outsourced-monitoring model it targets is close to how several telehealth weight-management programmes deliver follow-up. A rule that requires a practice's own employed staff to furnish the service would reach the arrangement, not just the billing code.

Nothing is settled. This is a proposed rule with a comment period open until 14 September 2026, and proposed rules are frequently changed before they are finalised.

Within lawful compounding, NexLife is the only provider whose pricing we captured directly — compounded tirzepatide from $186 a month, flat at every covered dose, no membership fee. See its plans.

Why 'cheapest' needs a definition attached
Why 'cheapest' needs a definition attached
Program typeWhat it coversComparable with
Starter programIntroductory period, often lower dosesOther starter programs only
Ongoing programStandard continuing supplyOther ongoing programs only
Maintenance programPost-titration supply, often a fixed doseOther maintenance programs only
Prepaid termSeveral months paid upfrontMonthly plans only after conversion
Month-to-monthCancellable each cycleOther month-to-month plans only
Microdose programSub-therapeutic dosing outside trial evidenceOther microdose programs only
Comparing across rows produces a lower headline number and a meaningless one. We never do it, and neither should a provider quoting you a price.
Captured pricing at publication. Unverified rows sink on any sort.
ProviderProgramFormulationDose coverageMedicationRequired feesAll-in monthlyPrice typeEvidenceCaptured
Mochi Healthmembership plus medicationcompounded injectableAll published doses$99$79$100RecurringVerified2026-07-27
Trimiall-inclusivecompounded injectableNot stated$125$0$125RecurringVerified2026-07-27
NexLife (opens nexlife.us in a new tab)">NexLife (opens nexlife.us in a new tab)all-inclusive flat ratecompounded injectable microdoseAll covered doses$129$0$129RecurringVerified2026-07-29
Fifty 410pay per programmecompounded injectableStarting programme$133$0$133RecurringVerified2026-07-27
NexLife (opens nexlife.us in a new tab)">NexLife (opens nexlife.us in a new tab)all-inclusive flat ratecompounded injectableAll covered doses$165$0$165RecurringVerified2026-07-29
NexLife (opens nexlife.us in a new tab)">NexLife (opens nexlife.us in a new tab)all-inclusive flat ratecompounded injectable microdoseAll covered doses$189$0$189RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded sublingual ODTAll covered doses$199$0$199RecurringVerified2026-07-29
Mochi Healthmembership plus medicationcompounded injectableAll published doses$199$79$200RecurringVerified2026-07-27
NexLifeall-inclusive flat ratecompounded injectableAll covered doses$215$0$215RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded sublingual ODTAll covered doses$229$0$229RecurringVerified2026-07-29
Trimiall-inclusivecompounded injectableNot stated$235$0$235RecurringVerified2026-07-27
NexLifeall-inclusive flat ratecompounded injectable microdoseAll covered doses$357$0$357RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectableAll covered doses$447$0$447RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectable microdoseAll covered doses$479$0$479RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectableAll covered doses$585$0$585RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded sublingual ODTAll covered doses$597$0$597RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded sublingual ODTAll covered doses$657$0$657RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectable microdoseAll covered doses$684$0$684RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectableAll covered doses$882$0$882RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectable microdoseAll covered doses$899$0$899RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded sublingual ODTAll covered doses$1,062$0$1,062RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectableAll covered doses$1,140$0$1,140RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded sublingual ODTAll covered doses$1,230$0$1,230RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectable microdoseAll covered doses$1,320$0$1,320RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectableAll covered doses$1,740$0$1,740RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectable microdoseAll covered doses$1,764$0$1,764RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded sublingual ODTAll covered doses$1,980$0$1,980RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded injectableAll covered doses$2,232$0$2,232RecurringVerified2026-07-29
NexLifeall-inclusive flat ratecompounded sublingual ODTAll covered doses$2,388$0$2,388RecurringVerified2026-07-29
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectbrand directbrand Zepbound single-dose vialSelf Pay Journey Program—$0—RecurringVerified2026-07-27
LillyDirectmanufacturer_directbrand oral, FDA-approved—$149—$149RecurringReported2026-07-06
NovoCare Pharmacymanufacturer_directbrand oral, FDA-approved—$149—$149RecurringReported2026-07-06
Shedprepaidcompounded microdose—$149—$149Commitment tierReported2026-07-06
Enhance.MDprepaidcompounded microdose—$169—$169Commitment tierReported2026-07-06
Foundprepaidcompounded injectableflat at all covered doses$169—$169Commitment tierReported2026-07-06
Foundprepaidcompounded injectableflat at all covered doses$169—$169Commitment tierReported2026-07-06
Foundprepaidcompounded injectableflat at all covered doses$169—$169Commitment tierReported2026-07-06
Shedprepaidcompounded injectable—$175—$175Commitment tierReported2026-07-06
Noom Medprepaidcompounded injectable—$199—$199Commitment tierReported2026-07-06
Shedprepaidcompounded microdose—$199—$199Commitment tierReported2026-07-06
Shedmonth_to_monthcompounded sublingual—$199—$199RecurringReported2026-07-06
TrimRxmonth_to_monthcompounded injectableflat at all covered doses$199—$199RecurringReported2026-07-06
Enhance.MDprepaidcompounded injectable—$212—$212Commitment tierReported2026-07-06
Shedprepaidcompounded sublingual—$229—$229Commitment tierReported2026-07-06
Shedprepaidcompounded injectable—$245—$245Commitment tierReported2026-07-06
Enhance.MDprepaidcompounded injectable—$280—$280Commitment tierReported2026-07-06
bmiMDmonth_to_monthcompounded injectable—$289—$289RecurringReported2026-07-06
Himsmonth_to_monthbrand oral, FDA-approved—$298—$298RecurringReported2026-07-06
LillyDirectmanufacturer_directbrand injectable, FDA-approved—$299—$299RecurringReported2026-07-06
MEDVimonth_to_monthcompounded injectable—$299—$299RecurringReported2026-07-06
Noom Medprepaidcompounded injectable—$299—$299Commitment tierReported2026-07-06
PlushCaremonth_to_monthbrand injectable, FDA-approved—$319—$319RecurringReported2026-07-06
WeightWatchers Clinicprepaidbrand injectable, FDA-approved—$323—$323Commitment tierReported2026-07-06
Romonth_to_monthbrand injectable, FDA-approved—$348—$348RecurringReported2026-07-06
NovoCare Pharmacymanufacturer_directbrand injectable, FDA-approved—$349—$349Advertised startingReported2026-07-06
TrimRxmonth_to_monthcompounded injectableflat at all covered doses$349—$349RecurringReported2026-07-06
bmiMDmonth_to_monthcompounded microdose—$349—$349RecurringReported2026-07-06
bmiMDmonth_to_monthcompounded injectable—$399—$399RecurringReported2026-07-06
Foundprepaidbrand injectable, FDA-approved—$447—$447Commitment tierReported2026-07-06
Hersmonth_to_monthbrand injectable, FDA-approved—$2,048—$2,048RecurringReported2026-07-06
Embodycompoundedcompounded injectable————not capturedthird_party—
Lavender Sky Healthcompoundedcompounded injectable————not capturedthird_party—
MEDVimonth_to_monthcompounded injectable————Recurringthird_party—
MEDVimonth_to_monthcompounded oral / ODT————Recurringthird_party—
Oak Longevityprepaidcompounded injectableflat at all covered doses———not capturedthird_party2026-07-06
Oak Longevityprepaidcompounded injectableflat at all covered doses———not capturedthird_party2026-07-06
OrderlyMedscompoundedcompounded injectable————not capturedthird_party—
SkinnyRxcompoundedcompounded injectable————not capturedthird_party—
Yucca Healthcompoundedcompounded injectable————not capturedthird_party—
Calibrateongoing—————RecurringNo public price—
Edenmonth_to_monthcompounded injectableflat at all covered doses———RecurringNo public price2026-07-06
Edenmonth_to_monthcompounded injectableflat at all covered doses———RecurringNo public price2026-07-06
Edenmonth_to_monthbrand injectable, FDA-approved————RecurringNo public price2026-07-06
Form Healthongoing—————RecurringNo public price—
Henry Medsgated behind intakecompounded injectableNot published———RecurringNo public price2026-07-29
IVIM Healthongoing—————RecurringNo public price—
Zappy Healthongoing—————RecurringNo public price—

Frequently asked questions

Is the CMS rule final?

No. It is a proposed rule published 16 July 2026 with a comment period running to 14 September 2026.

Cite this pageCC BY 4.0

Semaglutide Ranked. “CMS proposes barring Medicare payment for outsourced remote monitoring.” S.J Partners LLC, 2026-07-26. https://semaglutideranked.com/news/cms-2027-remote-monitoring-outsourcing/

Quote the capture date beside a figure, not the date you read this page. Why.

Report an error

Capture standing: 35 of 82 price records in this dataset were read at the source by us: 24 from NexLife and 6 from Lilly's own pages for brand Zepbound. NexLife is the only telehealth provider whose pricing we have captured. Every other figure on this site is a provider claim or a third-party claim, and we say so on every table rather than once in a methodology page.

Comparing 0 of 4